COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a
pandemic disease and is the major cause of deaths worldwide. The clinical complexities …

The COVID-19 pneumonia is a devastating disease without any approved treatment until
now [1]. Kirkby and Mackenzie discussed the potential of lungs low dose radiation therapy …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of
the coronavirus disease 2019 (COVID-19), has caused more than 179 million infections and …

(16). Glycine also blunted endotoxin-induced superoxide and proinflammatory cytokine TNF-
o production in alveolar macrophages (17). Glycine has been further shown to have anti …

The new coronavirus COVID-19 disease caused by SARS-CoV-2 was declared a global
public health emergency by WHO on Jan 30, 2020. Despite massive efforts from various …

Background: Novel Corona Virus Disease 2019 (COVID-19) can affect multiple organs,
including the lungs, resulting in pneumonia. Apart from steroids, other anti-COVID drugs that …

Fatal cases of COVID-19 are characterised by acute respiratory distress syndrome (ARDS),
sepsis, pneumonia and respiratory failure [1]. The high transmission rate of the virus and the …

Since early April 2020, there has been intense debate over proposed clinical use of ionizing
radiation to treat life-threatening pneumonia in Coronavirus Disease 2019 (COVID-19) …

As of May 31, 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
infected more than 6.1 million people worldwide, and more than 370,000 have now died …

Purpose Low-dose radiation therapy (LD-RT) has been shown to have an anti-inflammatory
effect, and preliminary results suggest it is feasible to treat patients with coronavirus disease …